MétaCan
Menu
Back to cohort

1350 AI/ML-driven discovery of Collagen Triple Helix Repeat-Containing 1, CTHRC1, a novel proteoglycan for disruption of stromal barriers and enhancement of immunotherapy responses in desmoplastic tumors

2022· article· en· W4308381384 on OpenAlexaff
Elizabeth A. Koch, Amy Berkley, Sean Phippen, Max London, Kerry White, Amanda Hanson, Sam Cooper, Christopher J. Harvey, Michael Briskin

Bibliographic record

VenueRegular and Young Investigator Award Abstracts · 2022
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsToronto Centre for Phenogenomics
Fundersnot available
KeywordsStromal cellCancer-Associated FibroblastsCancer researchTumor microenvironmentBreast cancerCancer immunotherapyPancreatic cancerMedicineImmunotherapyCancerImmune systemImmunologyInternal medicineTumor cells

Abstract

fetched live from OpenAlex

<h3>Background</h3> While checkpoint inhibitors (CPIs) such as anti-CTLA-4 and anti-PD-1/L1 have demonstrated efficacy in many solid tumor indications, those with high stromal presence have been difficult to treat. We aimed to use a proprietary machine learning/artificial intelligence platform to identify novel stromal targets that, upon targeting, will relieve this immunosuppressive barrier and increase CPI responsiveness in difficult-to-treat indications. <h3>Methods</h3> Based on bioinformatic analysis using a large single-cell RNA atlas, we assessed cancer-associated fibroblasts (CAFs)/fibroblastic cells in cancer tissue for the identification of novel targets, including proteoglycans. Antibodies were generated by immunization of humanized mice. Lead antibodies demonstrated potent <i>in vitro</i> activity in inhibiting cell adhesion and reducing survival of pancreatic cancer cells in CAF conditioned media. We assessed efficacy and PD (flow cytometry and IHC) in the EMT6 orthotopic tumor model in immunocompetent mice. <h3>Results</h3> Analysis of a large single-cell RNA atlas spanning many solid tumors identified CTHRC1 as one of the most upregulated CAF targets in the genome. CTHRC1 was also highly associated with CAFs from immune-excluded and desert-like tumor samples. Finally, we also find that CTHRC1 is highly expressed by both cancer cells and CAFs within the tumor, in key indications such as breast, ovarian, and pancreatic, with the potential for Fc-mediated depletion of both tumor and fibroblast cells. Profiling by scRNAseq of syngeneic tumor cells identified EMT6 breast cancer model as representative of human tumor, mirroring both CAF and tumor CTHRC1 expression. Assessment of efficacy demonstrated monotherapy activity with strong combination activity and enhanced survival when we combined anti-CTHRC1 mAbs with anti-PD-1. <h3>Conclusions</h3> We have identified CTHRC1 as a novel proteoglycan expressed by both CAFs and tumor cells that appears to be an ideal target for inhibiting of stromal barrier function with therapeutic monoclonal antibodies that may also serve as ideal for targeting payloads to the tumor microenvironment. These data demonstrate the power of large scRNA atlases for novel target ID and show the potential of breaking down stromal barriers in opening up tumor microenvironments to immune attack. <h3>Ethics Approval</h3> Animal studies were conducted in accordance with an Animal Use Protocol 6323.3 approved by the University Health Network Animal Care Committee.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.028
Threshold uncertainty score0.667

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.246
Teacher spread0.236 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueRegular and Young Investigator Award AbstractsSame topicCancer Genomics and DiagnosticsFrench-language works237,207